Derivados selenados como terapia frente a cáncer, tripanosomas y otras patologías
SECALE
University of Szeged
Szeged, HungríaPublicaciones en colaboración con investigadores/as de University of Szeged (7)
2022
-
Pharmaceutical and Safety Profile Evaluation of Novel Selenocompounds with Noteworthy Anticancer Activity
Pharmaceutics, Vol. 14, Núm. 2
2019
-
Antiviral, antimicrobial and antibiofilm activity of selenoesters and selenoanhydrides
Molecules, Vol. 24, Núm. 23
-
Organoselenium compounds as novel adjuvants of chemotherapy drugs—a promising approach to fight cancer drug resistance
Molecules, Vol. 24, Núm. 2
-
Selenocompounds as novel antibacterial agents and bacterial efflux pump inhibitors
Molecules, Vol. 24, Núm. 8
-
Selenoesters and selenoanhydrides as novel agents against resistant breast cancer
Anticancer Research, Vol. 39, Núm. 7, pp. 3777-3783
2017
-
Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line
Bioorganic and Medicinal Chemistry Letters, Vol. 27, Núm. 4, pp. 797-802
2016
-
Identification of selenocompounds with promising properties to reverse cancer multidrug resistance
Bioorganic and Medicinal Chemistry Letters, Vol. 26, Núm. 12, pp. 2821-2824